Drug intelligence / Profile preview

CAP Herbal Mint

Development stage: Unknown
Administration: Topical

Overview

CAP Herbal Mint is a sunscreen lip balm product designed to provide sun protection. Clinical studies have been conducted to evaluate its static Sun Protection Factor (SPF) and 80-minute water-resistant SPF, following the methodology described in the Food and Drug Administration (FDA) Final Rule (2011). It is applied topically to protect the lips and skin from ultraviolet (UV) radiation.

Brand names: CAP Herbal Mint
Other names: CAP Herbal Mint Flavour

Targets

CYP1A2 (Cytochrome P450 1A2)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)Nicotinic Acetylcholine ReceptorCaV3 (Caveolin-3)CYP3A4 (Cytochrome P450 3A4)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on CAP Herbal Mint.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAP Herbal Mint.

Explore the full profile